Aneri B. Balar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aneri B. Balar has a total of 237 co-authors. Here are the top co-authors by number of shared publications:
- Dhairya A. Lakhani
Department of Neuroradiology, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV 26506, USA
36 shared publications - Vivek Yedavalli
Division of Neuroradiology, Department of Radiology and Radiological Sciences, Johns Hopkins University, Baltimore, Maryland, USA
16 shared publications - Adam Andrew Dmytriw
Nuffield Department of Surgical Sciences, Medical Sciences Division, University of Oxford, Oxford, United Kingdom
15 shared publications - Hamza Adel Salim
Department of Neuroradiology, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA
14 shared publications - Tobias Djamsched Faizy
Neuroendovascular Program, Department of Radiology, University Hospital Muenster, Muenster, Germany
13 shared publications - Kambiz Nael
Department of Radiology & Biomedical Imaging, University of California, San Francisco, California, USA
11 shared publications
Latest Publications
- 4 March 2026
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (3) , 604-610
Gradation of Prolonged Venous Transit on Perfusion Imaging Highlights the Association of Deep Venous Drainage Impairment with Unfavorable Functional Outcome in Successfully Reperfused Anterior Circulation Large-Vessel-Occlusion Stroke
Prolonged venous transit (PVT), derived from perfusion imaging, serves as a surrogate for venous outflow (VO) impairment and has been associated with worse outcomes in acute ischemic stroke due to large-vessel occlusion (AIS-LVO). However, the differential impact of superficial-versus-deep venous drainage impairment on functional outcomes remains unclear. PVT1 and PVT2 were used as surrogates for superficial and deep VO impairment, respectively. We retrospectively analyzed 128 patients with AIS-LVO from a prospective registry who underwent successful mechanical thrombectomy (modified TICI 2b/2c/3) with available baseline CTP and 90-day mRS scores. PVT- was defined as the absence of time-to-maximum (Tmax) ≥10 seconds in the posterior superior sagittal sinus (SSS) or torcula (no VO impairment). PVT1 was defined as the presence of Tmax ≥10 seconds in the posterior SSS only (superficial VO impairment); and PVT2, as the presence of Tmax ≥10 seconds at the torcula with or without posterior SSS involvement (deep VO impairment). Multivariable logistic regression assessed the association between PVT gradation and the 90-day mRS score. The proportion of patients achieving favorable outcomes (mRS ≤2) declined stepwise across the PVT gradation: 60.9% in PVT-, 42.1% in PVT1, and 22.7% in PVT2. After we adjusted for age, admission NIHSS score, hypertension, hemorrhagic transformation, IV thrombolysis, and the modified TICI score, PVT gradation remained independently associated with reduced odds of favorable outcome. This association was primarily driven by the PVT2 group, with an adjusted OTR of 0.230 (95% CI, 0.068-0.780) compared with PVT- group. PVT gradation based on Tmax ≥10 seconds timing in distinct venous territories provides prognostic insight into the differential contributions of superficial-versus-deep venous drainage dysfunction, supporting the use of PVT as a meaningful VO imaging biomarker. Deep VO impairment, as reflected by PVT2, is the primary driver of worse functional outcomes despite successful reperfusion in AIS-LVO, indicating its stronger negative prognostic impact compared with superficial VO impairment. These findings can help inform prognosis and postacute management strategies.
- 4 March 2026
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (3) , 604-610
Gradation of Prolonged Venous Transit on Perfusion Imaging Highlights the Association of Deep Venous Drainage Impairment with Unfavorable Functional Outcome in Successfully Reperfused Anterior Circulation Large-Vessel-Occlusion Stroke
Prolonged venous transit (PVT), derived from perfusion imaging, serves as a surrogate for venous outflow (VO) impairment and has been associated with worse outcomes in acute ischemic stroke due to large-vessel occlusion (AIS-LVO). However, the differential impact of superficial-versus-deep venous drainage impairment on functional outcomes remains unclear. PVT1 and PVT2 were used as surrogates for superficial and deep VO impairment, respectively. We retrospectively analyzed 128 patients with AIS-LVO from a prospective registry who underwent successful mechanical thrombectomy (modified TICI 2b/2c/3) with available baseline CTP and 90-day mRS scores. PVT- was defined as the absence of time-to-maximum (Tmax) ≥10 seconds in the posterior superior sagittal sinus (SSS) or torcula (no VO impairment). PVT1 was defined as the presence of Tmax ≥10 seconds in the posterior SSS only (superficial VO impairment); and PVT2, as the presence of Tmax ≥10 seconds at the torcula with or without posterior SSS involvement (deep VO impairment). Multivariable logistic regression assessed the association between PVT gradation and the 90-day mRS score. The proportion of patients achieving favorable outcomes (mRS ≤2) declined stepwise across the PVT gradation: 60.9% in PVT-, 42.1% in PVT1, and 22.7% in PVT2. After we adjusted for age, admission NIHSS score, hypertension, hemorrhagic transformation, IV thrombolysis, and the modified TICI score, PVT gradation remained independently associated with reduced odds of favorable outcome. This association was primarily driven by the PVT2 group, with an adjusted OTR of 0.230 (95% CI, 0.068-0.780) compared with PVT- group. PVT gradation based on Tmax ≥10 seconds timing in distinct venous territories provides prognostic insight into the differential contributions of superficial-versus-deep venous drainage dysfunction, supporting the use of PVT as a meaningful VO imaging biomarker. Deep VO impairment, as reflected by PVT2, is the primary driver of worse functional outcomes despite successful reperfusion in AIS-LVO, indicating its stronger negative prognostic impact compared with superficial VO impairment. These findings can help inform prognosis and postacute management strategies.
Activity measure post‐acute care score for discharge outcomes is associated with prolonged venous transit on perfusion imaging in reperfused large vessel occlusion strokes
Background: Activity Measure for Post‐Acute Care (AM‐PAC) score is used in discharge planning for patients with acute ischemic stroke from a large vessel occlusion (AIS‐LVO). Prolonged venous transit (PVT) is a binary, qualitative measure visually ascertained from computed tomography perfusion imaging time‐to‐maximum (Tmax) maps. PVT has been associated with unfavorable recovery and mortality. Objective: To assess the robustness of PVT by evaluating its association with AM‐PAC. Methods: Consecutive adult patients with AIS‐LVO treated successfully with reperfusion therapy were retrospectively reviewed. PVT+ is defined as Tmax 10 seconds timing on at least one of the following: superior sagittal sinus and/or torcula. PVT− lacks this in both regions. Primary outcome was favorable AM‐PAC score, defined as having both Basic Mobility Score 17 and Daily Activity Score 19. Logistic regressions in unmatched and 1:1 propensity score‐matched cohorts were performed. Results: Among 121 patients, the median age was 72 (interquartile range, 64–81) years. Favorable AM‐PAC scores occurred less often in PVT+ than PVT− patients (10.5% vs. 45.8%). PVT+ was associated with significantly reduced odds of favorable AM‐PAC score in multivariable regressions (PVT+ vs. PVT− odds ratio [OR]: 0.11, 95% confidence interval [CI]: 0.03–0.48, p = .01); the significant association furthermore persisted in the matched cohort analysis (PVT+ vs. PVT− OR: 0.73, 95% CI: 0.60–0.88, p < .001). Conclusion: PVT+ is independently associated with lower odds of favorable AM‐PAC scores at discharge. Logistically‐consistent associations with short‐term and long‐term clinical outcomes augment our understanding of PVT and further establish the potential of this novel imaging parameter as an informative metric in clinical practice.
Activity measure post‐acute care score for discharge outcomes is associated with prolonged venous transit on perfusion imaging in reperfused large vessel occlusion strokes
Background: Activity Measure for Post‐Acute Care (AM‐PAC) score is used in discharge planning for patients with acute ischemic stroke from a large vessel occlusion (AIS‐LVO). Prolonged venous transit (PVT) is a binary, qualitative measure visually ascertained from computed tomography perfusion imaging time‐to‐maximum (Tmax) maps. PVT has been associated with unfavorable recovery and mortality. Objective: To assess the robustness of PVT by evaluating its association with AM‐PAC. Methods: Consecutive adult patients with AIS‐LVO treated successfully with reperfusion therapy were retrospectively reviewed. PVT+ is defined as Tmax 10 seconds timing on at least one of the following: superior sagittal sinus and/or torcula. PVT− lacks this in both regions. Primary outcome was favorable AM‐PAC score, defined as having both Basic Mobility Score 17 and Daily Activity Score 19. Logistic regressions in unmatched and 1:1 propensity score‐matched cohorts were performed. Results: Among 121 patients, the median age was 72 (interquartile range, 64–81) years. Favorable AM‐PAC scores occurred less often in PVT+ than PVT− patients (10.5% vs. 45.8%). PVT+ was associated with significantly reduced odds of favorable AM‐PAC score in multivariable regressions (PVT+ vs. PVT− odds ratio [OR]: 0.11, 95% confidence interval [CI]: 0.03–0.48, p = .01); the significant association furthermore persisted in the matched cohort analysis (PVT+ vs. PVT− OR: 0.73, 95% CI: 0.60–0.88, p < .001). Conclusion: PVT+ is independently associated with lower odds of favorable AM‐PAC scores at discharge. Logistically‐consistent associations with short‐term and long‐term clinical outcomes augment our understanding of PVT and further establish the potential of this novel imaging parameter as an informative metric in clinical practice.
- 3 November 2025
- Published by Springer Nature in Neuroradiology
- Vol. 67 (11) , 3173-3184
Prolonged venous transit and clinical outcomes in anterior circulation large-vessel occlusion stroke with complete or near-complete reperfusion
Background Prolonged venous transit (PVT), indicative of impaired venous outflow, is linked to poor outcomes in acute ischemic stroke due to large-vessel occlusion (AIS-LVO) treated with mechanical thrombectomy (MT). This study investigated the prognostic significance of PVT in AIS-LVO patients achieving near-complete or complete reperfusion (mTICI 2c or 3). Methods Retrospective analysis of a prospective registry included AIS-LVO patients with anterior circulation occlusions, mTICI 2c or 3 after MT, and 90-day modified Rankin Scale (mRS) scores. PVT, defined as Tmax ≥ 10 s in the posterior superior sagittal sinus or torcula on pretreatment CT perfusion, was assessed. Outcomes were favorable recovery (mRS 0–2), excellent recovery (mRS 0–1), and 90-day mortality. Results Among 81 patients, 25 (31%) were PVT + and 56 (69%) were PVT−. Baseline characteristics were similar. PVT + patients had higher discharge NIH Stroke Scale scores and worse 90-day mRS scores (median mRS, 4.00 vs. 1.00; P < 0.001). Multivariable analysis showed PVT + independently predicted lower odds of favorable (OR, 0.18; 95% CI, 0.04–0.65; P = 0.013) and excellent outcomes (OR, 0.12; 95% CI, 0.02–0.52; P = 0.008) and higher 90-day mortality (OR, 4.11; 95% CI, 1.08-17.0; P = 0.041). Conclusions PVT is a strong negative prognostic marker in AIS-LVO patients with excellent reperfusion, associated with reduced functional recovery and increased 90-day mortality. PVT assessment may identify high-risk patients despite successful MT.
- 3 November 2025
- Published by Springer Nature in Neuroradiology
- Vol. 67 (11) , 3173-3184
Prolonged venous transit and clinical outcomes in anterior circulation large-vessel occlusion stroke with complete or near-complete reperfusion
Background Prolonged venous transit (PVT), indicative of impaired venous outflow, is linked to poor outcomes in acute ischemic stroke due to large-vessel occlusion (AIS-LVO) treated with mechanical thrombectomy (MT). This study investigated the prognostic significance of PVT in AIS-LVO patients achieving near-complete or complete reperfusion (mTICI 2c or 3). Methods Retrospective analysis of a prospective registry included AIS-LVO patients with anterior circulation occlusions, mTICI 2c or 3 after MT, and 90-day modified Rankin Scale (mRS) scores. PVT, defined as Tmax ≥ 10 s in the posterior superior sagittal sinus or torcula on pretreatment CT perfusion, was assessed. Outcomes were favorable recovery (mRS 0–2), excellent recovery (mRS 0–1), and 90-day mortality. Results Among 81 patients, 25 (31%) were PVT + and 56 (69%) were PVT−. Baseline characteristics were similar. PVT + patients had higher discharge NIH Stroke Scale scores and worse 90-day mRS scores (median mRS, 4.00 vs. 1.00; P < 0.001). Multivariable analysis showed PVT + independently predicted lower odds of favorable (OR, 0.18; 95% CI, 0.04–0.65; P = 0.013) and excellent outcomes (OR, 0.12; 95% CI, 0.02–0.52; P = 0.008) and higher 90-day mortality (OR, 4.11; 95% CI, 1.08-17.0; P = 0.041). Conclusions PVT is a strong negative prognostic marker in AIS-LVO patients with excellent reperfusion, associated with reduced functional recovery and increased 90-day mortality. PVT assessment may identify high-risk patients despite successful MT.
- 16 October 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (3) , 596-603
Prolonged Venous Transit Is Associated with Unfavorable Functional Outcomes in Large-Core Stroke
BACKGROUND AND PURPOSE: Large core acute ischemic stroke (AIS) caused by large vessel occlusion (LVO) is associated with high rates of disability despite mechanical thrombectomy (MT). Prolonged venous transit (PVT), a marker of impaired venous drainage on CT perfusion, has emerged as a potential prognostic indicator, but its role in large core AIS-LVO remains unclear. We aimed to test the hypothesis that PVT is independently associated with unfavorable functional outcomes in patients with large core AIS-LVO. MATERIALS AND METHODS: We conducted a retrospective cohort study using data from consecutive patients with AIS-LVO and large ischemic core volumes (ASPECTS 6s) and large core volumes (rCBF <30%). Other predictors included older age (adjusted OR 1.07, 95% CI 1.02 to 1.11, P=0.003), higher admission NIHSS (adjusted OR 1.16, 95% CI 1.05 to 1.29, P=0.005), and larger rCBF <30% volume (adjusted OR 1.02, 95% CI 1.00 to 1.04, P=0.032). CONCLUSIONS: PVT is independently associated with unfavorable outcomes in patients with large core AIS-LVO. These findings suggest PVT may serve as a prognostic marker, warranting further investigation and validation in larger prospective studies to guide treatment decisions in this high-risk population.
- 16 October 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (3) , 596-603
Prolonged Venous Transit Is Associated with Unfavorable Functional Outcomes in Large-Core Stroke
BACKGROUND AND PURPOSE: Large core acute ischemic stroke (AIS) caused by large vessel occlusion (LVO) is associated with high rates of disability despite mechanical thrombectomy (MT). Prolonged venous transit (PVT), a marker of impaired venous drainage on CT perfusion, has emerged as a potential prognostic indicator, but its role in large core AIS-LVO remains unclear. We aimed to test the hypothesis that PVT is independently associated with unfavorable functional outcomes in patients with large core AIS-LVO. MATERIALS AND METHODS: We conducted a retrospective cohort study using data from consecutive patients with AIS-LVO and large ischemic core volumes (ASPECTS 6s) and large core volumes (rCBF <30%). Other predictors included older age (adjusted OR 1.07, 95% CI 1.02 to 1.11, P=0.003), higher admission NIHSS (adjusted OR 1.16, 95% CI 1.05 to 1.29, P=0.005), and larger rCBF <30% volume (adjusted OR 1.02, 95% CI 1.00 to 1.04, P=0.032). CONCLUSIONS: PVT is independently associated with unfavorable outcomes in patients with large core AIS-LVO. These findings suggest PVT may serve as a prognostic marker, warranting further investigation and validation in larger prospective studies to guide treatment decisions in this high-risk population.
- 5 September 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (8) , 1749-1756
Composite arterial and venous collateral score on single-phase CTA predicts 90-day outcomes in anterior circulation large-vessel occlusion stroke
Background Collateral circulation influences clinical outcomes in patients with acute ischemic stroke due to anterior circulation large-vessel occlusion (LVO). While both arterial and venous collateral assessments on single-phase computed tomography angiography (CTA) have prognostic value, they have traditionally been evaluated independently. Purpose We developed the CTA Collateral Impairment Score (CCIS), a composite measure incorporating arterial (Tan) and venous (Cortical Venous Opacification Score (COVES)) scores, and investigated its association with 90-day functional outcomes. Materials and methods We conducted a retrospective cohort study including 1080 patients with anterior circulation LVO stroke across four comprehensive stroke centers. Patients were assigned a CCIS of 0 (preserved), 1 (moderate impairment), or 2 (severe impairment) based on predefined thresholds for Tan and COVES scores. Results Favorable outcomes (modified Rankin Scale (mRS) score 0–2) occurred in 66% of patients with CCIS 0, 32% with CCIS 1, and 17% with CCIS 2 (PConclusion CCIS, a composite arterial and venous collateral score derived from single-phase CTA, was strongly and independently associated with 90-day outcomes in anterior circulation LVO stroke. Its integration into acute stroke imaging assessment may improve risk stratification and guide therapeutic decisions.
- 5 September 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (8) , 1749-1756
Composite arterial and venous collateral score on single-phase CTA predicts 90-day outcomes in anterior circulation large-vessel occlusion stroke
Background Collateral circulation influences clinical outcomes in patients with acute ischemic stroke due to anterior circulation large-vessel occlusion (LVO). While both arterial and venous collateral assessments on single-phase computed tomography angiography (CTA) have prognostic value, they have traditionally been evaluated independently. Purpose We developed the CTA Collateral Impairment Score (CCIS), a composite measure incorporating arterial (Tan) and venous (Cortical Venous Opacification Score (COVES)) scores, and investigated its association with 90-day functional outcomes. Materials and methods We conducted a retrospective cohort study including 1080 patients with anterior circulation LVO stroke across four comprehensive stroke centers. Patients were assigned a CCIS of 0 (preserved), 1 (moderate impairment), or 2 (severe impairment) based on predefined thresholds for Tan and COVES scores. Results Favorable outcomes (modified Rankin Scale (mRS) score 0–2) occurred in 66% of patients with CCIS 0, 32% with CCIS 1, and 17% with CCIS 2 (PConclusion CCIS, a composite arterial and venous collateral score derived from single-phase CTA, was strongly and independently associated with 90-day outcomes in anterior circulation LVO stroke. Its integration into acute stroke imaging assessment may improve risk stratification and guide therapeutic decisions.
- 3 September 2025
- Published by SAGE Publications in Interventional Neuroradiology
Middle meningeal artery embolization for chronic subdural hematoma: Does statin therapy improve outcomes? A propensity score-matched analysis
Background: Chronic subdural hematoma (cSDH) is a common condition in older adults, often treated with surgical-evacuation, though recurrence rates can reach 30%. Middle meningeal artery embolization (MMAE) has emerged as a treatment alternative. Statins have been explored as adjunct therapies, but literature regarding their combined use with MMAE is limited. Methods: Using TriNetX platform, we divided patients with cSDH who underwent MMAE into two groups: with adjuvant statins and without. Additionally, we divided patients with cSDH who underwent MMAE + Surgery into two groups: with adjuvant statins and without. Propensity score matching was conducted to minimize baseline differences. Primary outcomes included unplanned readmissions, surgical-evacuations, and mortality within 6 months of diagnosis. Results: We identified 2371 patients with cSDH who underwent MMAE, 1631 underwent MMAE alone, and 740 underwent MMAE + Surgery. Among MMAE alone group, 393 patients received statin therapy. While MMAE + Surgery group had 188 patients who received statin therapy. There was no significant difference in unplanned readmission rates between statin and nonstatin groups among MMAE alone group (36.6% vs. 39.7%; odds ratio (OR): 0.88; 95% confidence interval (CI): 0.66–1.17; P = 0.375). Similarly, rates of surgical-evacuation and mortality were comparable between the two groups; to MMAE + Surgery group's results were similar. There was no significant difference in unplanned readmission rates between statin and nonstatin groups (38.2% vs. 33.7%; OR: 1.22; 95% CI: 0.79–1.88; P = 0.377). Repeat surgical-evacuation and mortality rates were comparable. Conclusion: This study demonstrates that adding statins to MMAE does not improve outcomes in terms of the studied outcomes. While MMAE remains an effective treatment, the role of adjunct medical therapies requires further investigation.
- 3 September 2025
- Published by SAGE Publications in Interventional Neuroradiology
Middle meningeal artery embolization for chronic subdural hematoma: Does statin therapy improve outcomes? A propensity score-matched analysis
Background: Chronic subdural hematoma (cSDH) is a common condition in older adults, often treated with surgical-evacuation, though recurrence rates can reach 30%. Middle meningeal artery embolization (MMAE) has emerged as a treatment alternative. Statins have been explored as adjunct therapies, but literature regarding their combined use with MMAE is limited. Methods: Using TriNetX platform, we divided patients with cSDH who underwent MMAE into two groups: with adjuvant statins and without. Additionally, we divided patients with cSDH who underwent MMAE + Surgery into two groups: with adjuvant statins and without. Propensity score matching was conducted to minimize baseline differences. Primary outcomes included unplanned readmissions, surgical-evacuations, and mortality within 6 months of diagnosis. Results: We identified 2371 patients with cSDH who underwent MMAE, 1631 underwent MMAE alone, and 740 underwent MMAE + Surgery. Among MMAE alone group, 393 patients received statin therapy. While MMAE + Surgery group had 188 patients who received statin therapy. There was no significant difference in unplanned readmission rates between statin and nonstatin groups among MMAE alone group (36.6% vs. 39.7%; odds ratio (OR): 0.88; 95% confidence interval (CI): 0.66–1.17; P = 0.375). Similarly, rates of surgical-evacuation and mortality were comparable between the two groups; to MMAE + Surgery group's results were similar. There was no significant difference in unplanned readmission rates between statin and nonstatin groups (38.2% vs. 33.7%; OR: 1.22; 95% CI: 0.79–1.88; P = 0.377). Repeat surgical-evacuation and mortality rates were comparable. Conclusion: This study demonstrates that adding statins to MMAE does not improve outcomes in terms of the studied outcomes. While MMAE remains an effective treatment, the role of adjunct medical therapies requires further investigation.
- Open Access
- 23 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (17) , 5960
Demographic and Premorbid Clinical Factors Predict Modified Rankin Score in Large and Medium Vessel Occlusion Ischemic Strokes
Background/Objectives: We report on the association of clinical, demographic, and peri- and intraoperative factors with patient outcomes in large- and, separately, medium-vessel acute ischemic stroke (AIS) occlusions treated with mechanical thrombectomy or medical thrombolysis. Increasingly, neuroimaging, particularly novel markers of collateral status, has become useful in predicting response to endovascular treatment (EVT) among AIS patients. However, the relationship between these neuroimaging markers, documented predictors of stroke outcomes, and post-EVT functional status in anterior circulation large-vessel occlusions (LVOs) as compared to medium-vessel occlusions (MeVOs) remains unclear. We evaluated whether shared predictors of 90-day post-EVT functional outcomes in LVO compared to MeVO AIS patients within our institution exist. Methods: We retrospectively evaluated AIS patients treated at our institution between 9 January 2017 and 10 January 2023. The following were the inclusion criteria were applied: (i) CTA confirmed anterior circulation large or medium vessel occlusion; (ii) diagnostic CT perfusion was performed; (iii) mechanical thrombectomy was performed. A low modified Rankin score (mRS) indicating good functional outcomes (i.e., functional independence) was defined as less than or equal to 2, in accordance with prior studies. Univariate and multivariate logistic regression analyses were conducted to determine associations between demographic, clinical, and radiologic factors and mRS ≤ 2. Results: A total of 249 LVO (mean age 65.3 ± 16.2, 53.8% female) and 91 MeVO (mean age 68.9 ± 13.3, 46.2% female) patients met the inclusion criteria. Upon multivariate regression adjusted for race, age, hypertension, diabetes mellitus, radiologic features, IV alteplase, admission NIHSS, and reperfusion status, young age (p = 0.004), low admission NIHSS (p = 0.0001), and good reperfusion status (p = 0.007) were associated with good functional outcomes in LVO stroke. By contrast, no factors were significantly associated with good functional outcomes in MeVO stroke. Conclusions: Known factors, including young age, low admission stroke severity, and successful reperfusion predict EVT outcomes in LVO stroke but not necessarily in MeVO stroke. Further studies regarding predictors of MeVO outcomes in nonsurgical cases, including collateral status, may guide optimal medical management for this population.
- 23 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (17) , 5960
Open AccessDemographic and Premorbid Clinical Factors Predict Modified Rankin Score in Large and Medium Vessel Occlusion Ischemic Strokes
Background/Objectives: We report on the association of clinical, demographic, and peri- and intraoperative factors with patient outcomes in large- and, separately, medium-vessel acute ischemic stroke (AIS) occlusions treated with mechanical thrombectomy or medical thrombolysis. Increasingly, neuroimaging, particularly novel markers of collateral status, has become useful in predicting response to endovascular treatment (EVT) among AIS patients. However, the relationship between these neuroimaging markers, documented predictors of stroke outcomes, and post-EVT functional status in anterior circulation large-vessel occlusions (LVOs) as compared to medium-vessel occlusions (MeVOs) remains unclear. We evaluated whether shared predictors of 90-day post-EVT functional outcomes in LVO compared to MeVO AIS patients within our institution exist. Methods: We retrospectively evaluated AIS patients treated at our institution between 9 January 2017 and 10 January 2023. The following were the inclusion criteria were applied: (i) CTA confirmed anterior circulation large or medium vessel occlusion; (ii) diagnostic CT perfusion was performed; (iii) mechanical thrombectomy was performed. A low modified Rankin score (mRS) indicating good functional outcomes (i.e., functional independence) was defined as less than or equal to 2, in accordance with prior studies. Univariate and multivariate logistic regression analyses were conducted to determine associations between demographic, clinical, and radiologic factors and mRS ≤ 2. Results: A total of 249 LVO (mean age 65.3 ± 16.2, 53.8% female) and 91 MeVO (mean age 68.9 ± 13.3, 46.2% female) patients met the inclusion criteria. Upon multivariate regression adjusted for race, age, hypertension, diabetes mellitus, radiologic features, IV alteplase, admission NIHSS, and reperfusion status, young age (p = 0.004), low admission NIHSS (p = 0.0001), and good reperfusion status (p = 0.007) were associated with good functional outcomes in LVO stroke. By contrast, no factors were significantly associated with good functional outcomes in MeVO stroke. Conclusions: Known factors, including young age, low admission stroke severity, and successful reperfusion predict EVT outcomes in LVO stroke but not necessarily in MeVO stroke. Further studies regarding predictors of MeVO outcomes in nonsurgical cases, including collateral status, may guide optimal medical management for this population.
- 21 August 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 46 (9) , 1800-1804
Interobserver and Intraobserver Variability in the Assessment of Prolonged Venous Transit in Anterior Circulation Large-Vessel Occlusion Ischemic Stroke
BACKGROUND AND PURPOSE: Prolonged venous transit (PVT) on time-to-maximum (Tmax) perfusion maps has been associated with worse outcomes in patients with acute ischemic stroke due to anterior circulation large-vessel occlusion (AIS-LVO). The qualitative nature of PVT assessment introduces potential variability, and its reproducibility has not been systematically evaluated. MATERIALS AND METHODS: In a retrospective study of patients with confirmed AIS-LVO, 2 board-certified neuroradiologists independently reviewed pretreatment Tmax maps to assess PVT in the posterior superior sagittal sinus and torcula. One reader repeated the assessment after 24 weeks at minimum. Interobserver and intraobserver variability were evaluated with Cohen unweighted κ coefficients. RESULTS: Among 194 patients, median age was 70 years (interquartile range, 62–79), and 57% were women. Interobserver agreement was substantial (κ = 0.79; 95% CI, 0.69–0.88), reflecting concordant classification in 178 of 194 patients. Intraobserver agreement was also strong (κ = 0.87; 95% CI, 0.79–0.94), with initial and repeat evaluations differing in 11 cases. CONCLUSIONS: Qualitative PVT assessment demonstrated substantial interobserver and almost perfect intraobserver reliability. These findings support the use of PVT as a consistent marker of impaired venous outflow in AIS-LVO. Future studies should explore automated or semiquantitative methods to further improve reproducibility and enhance clinical utility.
- 21 August 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 46 (9) , 1800-1804
Interobserver and Intraobserver Variability in the Assessment of Prolonged Venous Transit in Anterior Circulation Large-Vessel Occlusion Ischemic Stroke
BACKGROUND AND PURPOSE: Prolonged venous transit (PVT) on time-to-maximum (Tmax) perfusion maps has been associated with worse outcomes in patients with acute ischemic stroke due to anterior circulation large-vessel occlusion (AIS-LVO). The qualitative nature of PVT assessment introduces potential variability, and its reproducibility has not been systematically evaluated. MATERIALS AND METHODS: In a retrospective study of patients with confirmed AIS-LVO, 2 board-certified neuroradiologists independently reviewed pretreatment Tmax maps to assess PVT in the posterior superior sagittal sinus and torcula. One reader repeated the assessment after 24 weeks at minimum. Interobserver and intraobserver variability were evaluated with Cohen unweighted κ coefficients. RESULTS: Among 194 patients, median age was 70 years (interquartile range, 62–79), and 57% were women. Interobserver agreement was substantial (κ = 0.79; 95% CI, 0.69–0.88), reflecting concordant classification in 178 of 194 patients. Intraobserver agreement was also strong (κ = 0.87; 95% CI, 0.79–0.94), with initial and repeat evaluations differing in 11 cases. CONCLUSIONS: Qualitative PVT assessment demonstrated substantial interobserver and almost perfect intraobserver reliability. These findings support the use of PVT as a consistent marker of impaired venous outflow in AIS-LVO. Future studies should explore automated or semiquantitative methods to further improve reproducibility and enhance clinical utility.
- 24 July 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 257, 109071
Tranexamic acid with surgery vs. surgery alone for chronic subdural hematoma: Propensity score-matched analysis
- 24 July 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 257, 109071
Tranexamic acid with surgery vs. surgery alone for chronic subdural hematoma: Propensity score-matched analysis
- Open Access
- 15 July 2025
- Published by Elsevier in World Neurosurgery
- Vol. 201, 124275
Standalone Middle Meningeal Artery Embolization Versus Medical Management for Chronic Subdural Hematomas: A Multi-Institutional and Multinational Database Study
- 15 July 2025
- Published by Elsevier in World Neurosurgery
- Vol. 201, 124275
Open AccessStandalone Middle Meningeal Artery Embolization Versus Medical Management for Chronic Subdural Hematomas: A Multi-Institutional and Multinational Database Study